Agilent Technologies Inc.
AAgilent Technologies Inc. (A) is a global leader in life sciences, diagnostics, and applied chemical markets. It specializes in designing and manufacturing equipment and software for laboratory analysis, offering solutions for research, pharmaceutical development, and clinical diagnostics. The company originated from Hewlett-Packard's scientific instruments division and has established a strong presence in analytical instrumentation, testing, and measurement services.
Dividend History
Investors can expect a dividend payout of $0.26 per share, scheduled to be distributed in 68 days on January 28, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 28, 2026 | $0.26 | 2026-01-06 | 2026-01-06 |
| October 22, 2025 | $0.25 | 2025-09-30 | 2025-09-30 |
| July 23, 2025 | $0.25 | 2025-07-01 | 2025-07-01 |
| April 23, 2025 | $0.25 | 2025-04-01 | 2025-04-01 |
| January 22, 2025 | $0.25 | 2024-12-31 | 2024-12-31 |
Dividends Summary
- Agilent Technologies Inc. has issued 56 dividend payments over the past 14 years
- The most recent dividend was paid 30 days ago, on October 22, 2025
- The highest dividend payed out to investors during this period was $0.26 per share
- The average dividend paid during this period was $0.17 per share.
Company News
The global gene editing market is projected to grow from $11.29 billion in 2025 to $42.13 billion by 2034, with a CAGR of 15.76%. North America dominates the market, while CRISPR-Cas9 technology leads in market share. Key drivers include potential medical and agricultural applications.
Q2 earnings season shows strong performance with S&P 500 EPS growth at 11.8%, 81% of companies beating expectations. Favorable inflation data and potential Fed rate cuts create optimistic market conditions, with technology sector leading performance.
Wall Street paused as rising Treasury yields and upcoming Nvidia earnings and Fed minutes weighed on sentiment. The S&P 500 slipped 0.2%, with technology and communication services sectors avoiding losses.
Agilent Technologies has launched its new ProteoAnalyzer system, an automated parallel capillary electrophoresis solution for rapid, high-resolution protein analysis. The company has also strengthened its Diagnostics and Genomics Group (DCG) segment with various regulatory approvals and partnerships.
The article discusses three healthcare stocks that have historically performed well in the second half of the year: Intuitive Surgical, UnitedHealth Group, and Agilent Technologies. The author believes these stocks have strong fundamentals and growth potential, making them good long-term investments.
